Results of an international drug testing service for cryptomarket users

Introduction: User surveys indicate that expectations of higher drug purity are a key reason for cryptomarket use. In 2014-2015, Spain's NGO Energy Control conducted a 1-year pilot project to provide a testing service to cryptomarket drug users using the Transnational European Drug Information...

Full description

Bibliographic Details
Main Authors: Caudevilla, F., Ventura, M., Fornís, I., Barratt, Monica, Vidal, C., lladanosa, C., Quintana, P., Muñoz, A., Calzada, N.
Format: Journal Article
Published: Elsevier BV 2015
Online Access:http://hdl.handle.net/20.500.11937/18081
_version_ 1848749642059087872
author Caudevilla, F.
Ventura, M.
Fornís, I.
Barratt, Monica
Vidal, C.
lladanosa, C.
Quintana, P.
Muñoz, A.
Calzada, N.
author_facet Caudevilla, F.
Ventura, M.
Fornís, I.
Barratt, Monica
Vidal, C.
lladanosa, C.
Quintana, P.
Muñoz, A.
Calzada, N.
author_sort Caudevilla, F.
building Curtin Institutional Repository
collection Online Access
description Introduction: User surveys indicate that expectations of higher drug purity are a key reason for cryptomarket use. In 2014-2015, Spain's NGO Energy Control conducted a 1-year pilot project to provide a testing service to cryptomarket drug users using the Transnational European Drug Information (TEDI) guidelines. In this paper, we present content and purity data from the trial. Methods: 219 samples were analyzed by gas chromatography associated with mass spectrometry (GC/MS). Users were asked to report what substance they allegedly purchased. Results: 40 different advertised substances were reported, although 77.6% were common recreational drugs (cocaine, MDMA, amphetamines, LSD, ketamine, cannabis). In 200 samples (91.3%), the main result of analysis matched the advertised substance. Where the advertised compound was detected, purity levels (m. ±. SD) were: cocaine 71.6. ±. 19.4%; MDMA (crystal) 88.3. ±. 1.4%; MDMA (pills) 133.3. ±. 38.4. mg; Amphetamine (speed) 51.3. ±. 33.9%; LSD 123.6. ±. 40.5. µg; Cannabis resin THC: 16.5. ±. 7.5% CBD: 3.4. ±. 1.5%; Ketamine 71.3. ±. 38.4%. 39.8% of cocaine samples contained the adulterant levamisole (11.6. ±. 8%). No adulterants were found in MDMA and LSD samples. Discussion: The largest collection of test results from drug samples delivered from cryptomarkets are reported in this study. Most substances contained the advertised ingredient and most samples were of high purity. The representativeness of these results is unknown.
first_indexed 2025-11-14T07:24:11Z
format Journal Article
id curtin-20.500.11937-18081
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T07:24:11Z
publishDate 2015
publisher Elsevier BV
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-180812017-09-13T15:41:03Z Results of an international drug testing service for cryptomarket users Caudevilla, F. Ventura, M. Fornís, I. Barratt, Monica Vidal, C. lladanosa, C. Quintana, P. Muñoz, A. Calzada, N. Introduction: User surveys indicate that expectations of higher drug purity are a key reason for cryptomarket use. In 2014-2015, Spain's NGO Energy Control conducted a 1-year pilot project to provide a testing service to cryptomarket drug users using the Transnational European Drug Information (TEDI) guidelines. In this paper, we present content and purity data from the trial. Methods: 219 samples were analyzed by gas chromatography associated with mass spectrometry (GC/MS). Users were asked to report what substance they allegedly purchased. Results: 40 different advertised substances were reported, although 77.6% were common recreational drugs (cocaine, MDMA, amphetamines, LSD, ketamine, cannabis). In 200 samples (91.3%), the main result of analysis matched the advertised substance. Where the advertised compound was detected, purity levels (m. ±. SD) were: cocaine 71.6. ±. 19.4%; MDMA (crystal) 88.3. ±. 1.4%; MDMA (pills) 133.3. ±. 38.4. mg; Amphetamine (speed) 51.3. ±. 33.9%; LSD 123.6. ±. 40.5. µg; Cannabis resin THC: 16.5. ±. 7.5% CBD: 3.4. ±. 1.5%; Ketamine 71.3. ±. 38.4%. 39.8% of cocaine samples contained the adulterant levamisole (11.6. ±. 8%). No adulterants were found in MDMA and LSD samples. Discussion: The largest collection of test results from drug samples delivered from cryptomarkets are reported in this study. Most substances contained the advertised ingredient and most samples were of high purity. The representativeness of these results is unknown. 2015 Journal Article http://hdl.handle.net/20.500.11937/18081 10.1016/j.drugpo.2016.04.017 Elsevier BV fulltext
spellingShingle Caudevilla, F.
Ventura, M.
Fornís, I.
Barratt, Monica
Vidal, C.
lladanosa, C.
Quintana, P.
Muñoz, A.
Calzada, N.
Results of an international drug testing service for cryptomarket users
title Results of an international drug testing service for cryptomarket users
title_full Results of an international drug testing service for cryptomarket users
title_fullStr Results of an international drug testing service for cryptomarket users
title_full_unstemmed Results of an international drug testing service for cryptomarket users
title_short Results of an international drug testing service for cryptomarket users
title_sort results of an international drug testing service for cryptomarket users
url http://hdl.handle.net/20.500.11937/18081